Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain.
暂无分享,去创建一个
L. Hart | M. Simmonds | R. Portenoy | R. Rauck | A. Lyss | M. Simmonds | R. Payne | R. Berris | P. Coluzzi | L. Hart | M. Busch | E. Nordbrook | D. Loseth | Diane B. Loseth | Earl Nordbrook
[1] R. Portenoy,et al. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study , 1999, PAIN.
[2] M. Simmonds,et al. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Farrar,et al. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. , 1998, Journal of the National Cancer Institute.
[4] D. Benhamou,et al. Patient-controlled intranasal analgesia. , 1997, Anesthesia and analgesia.
[5] C. Spies,et al. Patient-Controlled Intranasal Analgesia: A Method for Noninvasive Postoperative Pain Management , 1996, Anesthesia and analgesia.
[6] C. Cleeland,et al. Pain and its treatment in outpatients with metastatic cancer. , 1994, The New England journal of medicine.
[7] D B Carr,et al. New clinical-practice guidelines for the management of pain in patients with cancer. , 1994, The New England journal of medicine.
[8] H. Striebel,et al. Intranasal fentanyl titration for postoperative pain management in an unselected population , 1993, Anaesthesia.
[9] H. Thaler,et al. Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect , 1992, Cancer.
[10] C. Akinsanya. Cancer pain relief and palliative care , 1992 .
[11] P. Glare,et al. Character of terminal illness in the advanced cancer patient. , 1991, Journal of pain and symptom management.
[12] M. Ashburn,et al. Absorption and bioavailability of oral transmucosal fentanyl citrate. , 1991, Anesthesiology.
[13] R. Portenoy,et al. Breakthrough pain: definition, prevalence and characteristics , 1990, Pain.
[14] K. Foley,et al. Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. , 1990, Journal of pain and symptom management.
[15] D. Duthie,et al. Pharmacokinetics of fentanyl during constant rate i.v. infusion for the relief of pain after surgery. , 1986, British journal of anaesthesia.
[16] Morton Rosenberg,et al. Management of Cancer Pain, Clinical Practice Guideline No. 9. , 1996 .